Virtus Biotech ETF
BBP
BBP
25 hedge funds and large institutions have $25.7M invested in Virtus Biotech ETF in 2026 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
11.84% more ownership
Funds ownership: 39.73% → 51.57% (+12%)
Holders
25
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.29M | |
| 2 | +$1.44M | |
| 3 | +$1.31M | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$998K |
| 5 |
Raymond James Financial
St Petersburg,
Florida
|
+$909K |
Top Sellers
| 1 | -$566K | |
| 2 | -$557K | |
| 3 | -$204K | |
| 4 |
FEM
Fulcrum Equity Management
Plano,
Texas
|
-$104K |
| 5 |
HIA
Harbor Investment Advisory
Lutherville,
Maryland
|
-$22K |